Kimberly Resnick
Papers
2
Total Citations
153
H-Index
2
About
Kimberly Resnick is a leading gynecologic oncologist whose research has significantly advanced the use of robotic surgery and stereotactic body radiosurgery (SBRT) for treating gynecologic malignancies. Her work centers on improving outcomes for women with complex, recurrent, or metastatic cancers by developing less invasive, high-precision treatment modalities. Resnick’s most impactful contribution is her phase II clinical trial on robotic SBRT for metastatic gynecologic cancers, which demonstrated the safety and efficacy of this ablative approach in managing difficult-to-treat recurrences, earning over 100 citations and shaping modern radiotherapy protocols. She also performed a critical analysis of robotic surgery complications, notably documenting the first case of small bowel evisceration through an 8-mm robotic trocar site after gynecologic cancer surgery—a finding that has informed surgical safety practices and garnered 50 citations. Through these studies, Resnick has not only expanded therapeutic options but also enhanced the understanding of procedural risks, directly influencing clinical guidelines. Her work remains essential reading for researchers and clinicians seeking to balance aggressive cancer control with reduced morbidity.
Research Focus
Key Achievements
Top Papers
- 1
- 2